Are Ranbaxy' woes over? - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Are Ranbaxy' woes over?

Mar 24, 2009

Light at the end of the tunnel for Ranbaxy
Ranbaxy must be breathing a sigh of relief. The UK and Australian regulatory authorities have given a clean chit to the company's Paonta Sahib facilities after the same was subject to investigation last year. This very facility had come under the scanner of the US FDA, which found manufacturing deficiencies in the plant. As a result, production at this site had been halted and an import ban on 30 drugs was imposed. This raised concerns among other countries to which Ranbaxy exports as well (UK and Australia being among them), thereby prompting them to conduct investigations on their own. Hence, the green signal from these countries is like a beacon in the sky for the beleaguered pharma company. That does not mean that it can export drugs from this plant in the US as yet. The issue with the US FDA is still to be resolved. And while the actions of one country does not necessarily influence that of the other, it certainly raises some hope that the standoff between Ranbaxy and the US FDA translates into some kind of a favourable resolution for the former.

Indian banks to receive a shot in the arm
Indian banks can pat themselves on their backs for not facing the kind of trouble that their Western counterparts are now facing. While the US and the European banking industry has burnt its fingers badly in the subprime crisis, RBI's prudent norms coupled with the under development of securitization in India, spared India's banks the ills that are afflicting the banks of the developed world. Despite that, India has not been completely immune from the crisis that has engulfed the global economy and the credit crunch that has hindered lending in the US and Europe is having some impact on the lending activities of Indian banks too.

Thus, as reported in the International Herald Tribune (IHT), the country's lenders are expected to raise several billion dollars in fresh equity over the next few quarters as bad debts rise and the Indian government pressures them to increase lending. Especially banks that have a capital adequacy ratio of less than 9% are coming under the government scanner. At least 17 state-run banks have a Tier 1 ratio of less than 7.5%, making them prime candidates for an equity infusion.

IHT further states from a report obtained by Reuters that Indian state-run banks will most likely raise US$ 4 bn to US$ 6 bn in the coming months. What also makes the case for additional capital all the more compelling is the estimation that Indian banks' gross bad loans will rise to 6.1% by 2011. Thus, while India on the whole is still better off than its global peers, its banks, nevertheless, will have to receive a shot in the arm if lending has to be spurred.

Equitymaster requests your view! Post a comment on "Are Ranbaxy' woes over?". Click here!


More Views on News

Your Queries on the 8-Year Cycle Answered (Fast Profits Daily)

Sep 25, 2020

You've sent in your queries on my videos on the 8-year greed and fear cycle in the market. I'll answer them in this video.

It's When You Sell that Counts (Profit Hunter)

Sep 25, 2020

How I alerted readers to the impending crash last week.

Can the Nifty Fall to 10,200? (Fast Profits Daily)

Sep 24, 2020

The Nifty has reached an important support level today. If it breaks then we could see further downside.

How to Save Money by Exiting Stocks Before They Fall podcast (Views On News)

Sep 24, 2020

A penny saved is a penny earned. It doesn't matter where you enter. All that matter is where you exit. Watch this video to identify an opportune time to exit your investments and book profits.

ICICI Prudential ESG Fund: Aims for Sustainability (Outside View)

Sep 24, 2020

PersonalFN briefly explains the newly launched fund : ICICI Prudential ESG Fund.

More Views on News

Most Popular

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

My Top Stock to Buy in this Market Selloff (Profit Hunter)

Sep 22, 2020

The recent correction offers a great opportunity to buy this high conviction smallcap stock.

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...

How Much Money Do You Need to Be a Professional Trader? (Fast Profits Daily)

Sep 17, 2020

In this video I'll answer a question I get asked often: How much capital do I really need to trade the markets for a living? Let's find out...


Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms


Sep 25, 2020 (Close)